Successful Use of Glycoprotein IIb/IIIa Inhibitor Involving Severely Ill COVID-19 Patient

Perm J. 2021 Dec 14;25:21.125. doi: 10.7812/TPP/21.125.ABSTRACTThis case report describes a successful outcome involving a patient with severe COVID-19 viral pneumonia utilizing a novel therapeutic approach with the glycoprotein IIb/IIIa inhibitor, eptifibatide.PMID:35348110 | PMC:PMC8784086 | DOI:10.7812/TPP/21.125
Source: The Permanente journal - Category: General Medicine Authors: Source Type: research